Home/Filings/4/0001501697-26-000009
4//SEC Filing

Bridger Gary 4

Accession 0001501697-26-000009

CIK 0001501697other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:00 PM ET

Size

283.4 KB

Accession

0001501697-26-000009

Insider Transaction Report

Form 4
Period: 2026-01-01
Bridger Gary
Director
Transactions
  • Award

    Stock Option (right to buy)

    2026-01-01+110,0000 total
    Exercise: $4.00Exp: 2036-01-01Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date.

Issuer

X4 Pharmaceuticals, Inc

CIK 0001501697

Entity typeother

Related Parties

1
  • filerCIK 0001600049

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:00 PM ET
Size
283.4 KB